Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
Sign Up to like & getrecommendations! Published in 2021 at "Mycopathologia"
DOI: 10.1007/s11046-021-00533-5
Abstract: Disseminated talaromycosis caused by Talaromyces marneffei is a life-threatening opportunistic infection. Although amphotericin B deoxycholate (dAmB) remains the first-line induction treatment, voriconazole can also be used. However, no clinical trials have compared dAmB and voriconazole… read more here.
Keywords: therapy talaromycosis; hiv; induction therapy; therapy ... See more keywords